A Retrospective Study of Treatment Patterns and Clinical Outcomes in Patients With Central Nervous System Tuberculosis
NCT06011915 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 638
Last updated 2023-08-28
Summary
This is a retrospective clinical study to analyze the clinical characteristics, complications, and effects of different treatment options on long-term prognosis in patients with central nervous system tuberculosis. All cases of central nervous system tuberculosis diagnosed between 2016 and 2021 were included in the electronic medical record system of one center, and data such as demographics, hospitalization information, clinical information, laboratory or imaging examinations, treatment plans, and outcomes were collected.
Conditions
- Central Nervous System Tuberculosis
Sponsors & Collaborators
-
Tongji Hospital
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-08-22
- Primary Completion
- 2023-07-26
- Completion
- 2023-07-26
Countries
- China
Study Locations
More Related Trials
-
Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
NCT06764576 ·Status: RECRUITING
-
Multi-Drug Resistant Tuberculosis in Korea
NCT00341601 ·Status: COMPLETED
-
Training Protocol on the Natural History of Tuberculosis
NCT01212003 ·Status: RECRUITING
-
Evaluation of Tuberculosis Treatment Outcomes
NCT06942975 ·Status: COMPLETED
-
Diagnosis of Tuberculous Meningitis by ESAT-6 in CSF
NCT01371916 ·Status: COMPLETED
-
Evaluation of Somatostatin Receptor Imaging Using PET/MRI as a Novel Approach to Detecting Pathology in Pulmonary TB
NCT02845570 ·Status: UNKNOWN ·Phase: PHASE1
-
Short-Course Anti-tuberculosis Regimens for Mild Spinal Tuberculosis
NCT06917495 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
NCT04148053 ·Status: UNKNOWN
-
Evaluation of PATHFAST-LAM as a Tuberculosis Treatment Monitoring Tool in Kenya
NCT07157904 ·Status: NOT_YET_RECRUITING
-
Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study
NCT01158755 ·Status: COMPLETED ·Phase: PHASE2
-
Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)
NCT05401071 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study
NCT02169882 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Utility of Intensified Case Finding Combined With a Package of Novel TB Diagnostics Using a Mobile Clinic in Africa
NCT01990274 ·Status: COMPLETED ·Phase: NA
-
Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination
NCT01119521 ·Status: COMPLETED ·Phase: PHASE1
-
Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation
NCT01802502 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
NCT04930978 ·Status: RECRUITING
-
Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)
NCT03559582 ·Status: COMPLETED
-
Metronidazole for Pulmonary Tuberculosis (South Korea)
NCT00425113 ·Status: COMPLETED ·Phase: PHASE2
-
MDR-TB Close Contacts Tracing in China (TCCT Study)
NCT04484129 ·Status: UNKNOWN
-
Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort
NCT03822156 ·Status: COMPLETED
-
The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis
NCT02477852 ·Status: UNKNOWN ·Phase: PHASE4
-
Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients
NCT06709157 ·Status: NOT_YET_RECRUITING
-
Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients
NCT05148949 ·Status: UNKNOWN ·Phase: PHASE4
-
Expression of Tuberculosis in the Lung
NCT00201253 ·Status: COMPLETED
-
Benin Population Diversity of Tuberculosis and Implications
NCT02744469 ·Status: COMPLETED